The European Federation for Medicinal Chemistry (EFMC) is an independent association representing medicinal chemistry societies in Europe. Its objective is to advance the science of medicinal chemistry by promoting cooperation and networking, by providing training and mentoring, by rewarding scientific excellence, and by facilitating communication and influencing stakeholders.

Meetings  December 2016 Next

Laureates 2016

The EFMC is pleased to announce the recipients of the 2016 Awards:

Nauta Award for Pharmacochemistry
Prof. François Diederich – ETH Zürich, Switzerland

For his outstanding contributions to the science of medicinal chemistry. Prof. François Diederich made essential contributions to the fundamental understanding of non-bonding interactions involved in molecular recognition and their application in modern drug design. His scientific work is documented in more than 700 publications and beautifully describes interactions such as sulfur-aromatics, cation-Pi, fluorine interactions and halogen bonding that are actively used by many scientists around the world in the discovery of novel drugs.

UCB-Ehrlich Award for Excellence in Medicinal Chemistry
Prof. Paul J. Hergenrother – University of Illinois at Urbana-Champaign, United States

For his groundbreaking work on procaspase-3 activation by a small molecule PAC-1, thereby inducing apoptosis in cancer cells. In his scientific research he uses natural products as starting points for complex molecule synthesis in an approach named “complexity-to-diversity”.  Next to basic research, he also aims to bring his novel compounds to the clinic for the benefit of patients.

Prous Institute-Overton and Meyer Award for New Technologies in Drug Discovery
Prof. Jan Steyaert – VIB & VU Brussels, Belgium

For his pioneering work in the field of nanobody-enabled structural biology. His nanobody technology led to X-ray crystallographic structures of GPCRs locked in an agonist-bound active conformational state and to the first view of a GPCR transmembrane signalling complex. These novel GPCR structures are now finding widespread use in the discovery of novel drugs.

The Awards will be presented during the XXIV International Symposium on Medicinal Chemistry (EFMC-ISMC 2016), scheduled to be held on August 28 – September 1, 2016 in Manchester, United Kingdom.

Photographer - Fabien Venturi
Contact: venturifab@yahoo.fr


Previous Laureates

Nauta Award for Pharmacochemistry
2014: Dr Paul Leeson, GlaxoSmithKline, United Kingdom
2012: Prof. Alexander Levitzki, THe Hebrew University of Jerusalem, Israel
2010: Prof. Camille George Wermuth, University Louis Pasteur Strasbourg and Prestwick Chemicals

UCB-Ehrlich Award for Excellence in Medicinal Chemistry
2014: Prof. Craig Crews, Yale University, Department of Chemistry, New Haven, USA
2012: Dr Krzysztof Józwiak, Department of Chemistry, Medical University of Lublin, Poland
2010: Dr Anthony Wood, Pfizer Global Research and Development

Prous Institute-Overton and Meyer Award for New Technologies in Drug Discovery
2014: Prof. György Ferenczy and Prof. György Keseru, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Budapest, Hungary
2012: Dr Harren Jhoti, Astex Pharmaceuticals, UK
2010: Prof. Klaus Müller, ETH Zürich, Switzerland




EFMC Awards at EFMC-ISMC 2016

The 2016 EFMC Awards have been conferred on occasion of the XXIV EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC), held in Manchester on August 28 - September 1, 2016.

Nauta Award for Pharmacochemistry
Prof. François Diederich – ETH Zürich, Switzerland

For his outstanding contributions to the science of medicinal chemistry. Prof. François Diederich made essential contributions to the fundamental understanding of non-bonding interactions involved in molecular recognition and their application in modern drug design. His scientific work is documented in more than 700 publications and beautifully describes interactions such as sulfur-aromatics, cation-Pi, fluorine interactions and halogen bonding that are actively used by many scientists around the world in the discovery of novel drugs.

UCB-Ehrlich Award for Excellence in Medicinal Chemistry
Prof. Paul J. Hergenrother – University of Illinois at Urbana-Champaign, United States

For his groundbreaking work on procaspase-3 activation by a small molecule PAC-1, thereby inducing apoptosis in cancer cells. In his scientific research he uses natural products as starting points for complex molecule synthesis in an approach named “complexity-to-diversity”.  Next to basic research, he also aims to bring his novel compounds to the clinic for the benefit of patients.

Prous Institute-Overton and Meyer Award for New Technologies in Drug Discovery
Prof. Jan Steyaert – VIB & VU Brussels, Belgium

For his pioneering work in the field of nanobody-enabled structural biology. His nanobody technology led to X-ray crystallographic structures of GPCRs locked in an agonist-bound active conformational state and to the first view of a GPCR transmembrane signalling complex. These novel GPCR structures are now finding widespread use in the discovery of novel drugs.

Photographer - Fabien Venturi
Contact: venturifab@yahoo.fr


M T W T F S S
28 29 30 01 02 03 04
05 06 07 08 09 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31 01
All events   |  Future events

Job portal

09/11/2016
Research and Innovation Manager, Antwerp University Association : IOF consortium Antwerp Drug Discovery Network (ADDN), Antwerp, Belgium
read more


28/10/2016
Research Position: DEVELOPING AND APPLYING SIMULATIONS METHODS FOR DRUG DISCOVERY, Acellera: -, Barcelona, Spain
read more


21/10/2016
Medicinal chemist, Selvita: Biotech/ R&D/ Science, Kraków, Poland
read more


21/10/2016
2 PhD positions in Med Chem and 9 Ph positons in BIO, University of Siena, and other TRACT Partners: Biotechlnology, Chemistry and Pharmacy, and other TRACT Partners, Siena, Italy
read more


13/10/2016
Junior Group Leader, Institut Curie: Chemical Biology of Membranes and Therapeutic Delivery Unit, Paris, France
read more


17/08/2016
Senior Project Manager Medicinal Chemistry, Mercachem: Medicinal Chemistry, Nijmegen, The Netherlands
read more


Job portal page

Follow us on Twitter

Follow us on LinkedIn

ChemBridgeBoehringer IngelheimNovartisProf Dr W. Th. Nauta FoundationPfizerServierRoche
 Prous Institute for Biomedical ResearchUCBJanssen R&DBayerMerck